NEW ORLEANS Esperion Therapeutics revealed long-awaited data on its heart pills efficacy in cutting severe cardiovascular outcomes, three years after the drug was cleared for use to lower cholesterol levels. The role of insurance and the value of what should be a celebrated national resource - the growing mountain of generic drugs - are overlooked and yet form the foundation of a workable solution.The Great American Drug Deal examines the healthcare landscape through the lens of this contract, including the government's role in inventing drugs, direct-to-consumer advertising, the opioid crisis, the price-jacking of old drugs, and the impact on America of lower drug costs in other countries. Dr. Kolchinsky's firm held 7.3 million Ascendis Pharma A/S (NASDAQ:ASND) shares in Q3, which were worth $1.17 billion and made up for 16.31% of its portfolio. Both Moffitt Cancer Center and Mayo Clinic in Florida, not too far from Domingos and his family, said he would have to wait between three and a half and four months to get the treatment. Quality, Value, Ownership Undervalued - Ebit/EV + B/M Blend Quality, Value, Momentum Activist Targets Dividend Yield Microcap with Revenue NCAV Screen Net Net Working Capital Negative Enterprise Value Piotroski Score ROIC Screen Short Volume Ratio High Insider Selling High Insider Buying The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Keri is also a writer and is currently working on a Southern gothic novel. . Please note GuruFocus will not track the insiders transaction performance if he/she does not have buying transactions. Above is the net worth, insider trading, and ownership report for Kolchinsky Peter. Tweet With huge thanks to RA Capital's Alex Martinez-Forte and Jacqueline Rhuda for extensive data analysis. Peter Kolchinsky / Published in City Journal / February 24, 2020 "Some health economists, such as those at the Institute for Clinical and Economic Review (ICER), believe that they can tell us the right price to pay for each new medicine that the FDA approves. 2004-2023 GuruFocus.com, LLC. This investment adviser does not provide advice to individual investors. "Stay tuned for more covid and science explainers. These two energetic couples are living their dream with energy, imagination, creativity and a whole lot of savvy business sense. Peter Kolchinsky owns about 10,916,567 units of Solid Biosciences Inc common stock. One hopeful voice is biotech investor Peter Kolchinsky, the founder of RA Capital Management. As for Peter, As soon as we get the house in order, Im looking forward to some fishing. Insider trading is most common in March, with the busiest year in 2015. May 27, 2022 (This is a long piece; click here to read it in Bionic Reading format, which may for some increase reading speed and comprehension. Here we are at the BHI after a day of ripping out tile and installing shoe molding: And heres an article about us from The Vermont Standard that we thought you might enjoy. Health Care. In total, Peter Kolchinsky has made about 5 transactions over a year of their time at Solid Biosciences Inc. The singer-songwriter and actress is the latest celebrity addition to Merz Aesthetics Beauty on Your Terms campaign for Botox rival Xeomin. Warren Buffett has made it clear. The current estimated net worth of Solid Biosciences Inc's Director, Peter Kolchinsky, is estimated to be about $2.89B . He co-founded and runs the Boston-based investment firm RA Capital Management; writes and teaches about biomedical entrepreneurship and its potential to transform global health; serves on the boards of several public and private drug development companies; and lives in Massachusetts with his historian/equestrian wife, strong-willed children, and reasonably well-trained dog. , Keri said, adding that she hopes the new business still allows her some time for her own writing. and Peter Kolchinsky, Director But many people worry that Covid-19 will mutate and . Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. Fundamental company data provided by Morningstar, updated daily. The companies RA Capital expects to build will range from single-assets to broad platforms, spanning early discovery through late clinical stage, across all therapeutic areas, such as neurology, rare disorders, oncology, and cardiovascular disease, said Levin in a prepared statement. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. out how to maintain the house themselves, from the roof to the, Anna and Keri hope their husbands dont electroc, can be found busily working at The Blue Horse Inn most weekends. Peter Kolchinsky and Raj Shah raise a $300M fund devoted to biotech startups John Carroll Editor & Founder Josh Resnick RA Capital Peter Kolchinsky and Raj Shah have another $300. The fund was seeded by Vertex Pharma co-founder Rich Aldrich, who invested $4 million at . (LogOut/ The largest trade he's ever made was buying 4,545,455 units of Wave Life Sciences stock on 11 December 2018 worth over $50,000,005. the community will feel welcome. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. Couple Number Two: Ben Ford and Keri Cole: Ben Ford was born and raised in Ames, Iowa. Peter Kolchinsky is the Director, 10% Owner of Synthorx Inc and owns about 14,903,741 shares of Synthorx Inc (THOR) stock worth over $1.0 Billion . He currently manages a fund that invests in healthcare and biotechnology companies. He holds a BA from Cornell University and a PhD in Virology from Harvard University. Dr. Kolchinsky earned his Ph.D. in virology from Harvard University and earned his bachelors degree in Biology from Cornell University. Hedge Fund Net Worth $4.93B Peter Kolchinsky manages more assets than 43% of other Hedge Fund Managers Average Return +0.32% Since Last Filing Last 12 Months 3 Years (Annualized) Portfolio Breakdown by Sector Portfolio Breakdown 97.31% Healthcare 1.12% Services 0.78% Technology 0.51% Financial RA Capital Management Portfolio Activity Company Name In total, Peter Kolchinsky has made about 2 transactions recently at Mineralys Therapeutics, Inc. All Rights Reserved. Couple Number One: Peter and Anna Kolchinsky: Peter Kolchinsky grew up in the Boston area, studied biology at Cornell, and has a PhD in Virology from Harvard. The co-heads of the venture at RA are Josh Resnick and Andrew Levin, working with 9 other professionals. So they invited their close friends Keri and Ben up for what they expected to be a reality check. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. Refer a Friend and Earn One Month of Free Membership. Required fields are marked *. Save my name, email, and website in this browser for the next time I comment. $140.3K . In the companys CLEAR study of nearly 14,000 patients, Esperions drug Nexletol cut the combined risk of heart attack, stroke, cardiovascular death or the need for coronary revascularization by 13%, compared with placebo. They fell in love with the historic character and natural beauty of the area and, as they met more of the towns residents, realized that Woodstock was a community that they would like to be part of. Peter Kolchinsky Net Worth The estimated Net Worth of Peter Kolchinsky is at least Wave Life Sciences stock worth over $36,046,604 and over the last 8 years he sold WVE stock worth over $58,095,632. Peter Kolchinsky started RA Capital Management after completing his Ph.D. in virology from Harvard in 2001. Insider trading is most common in February, with the busiest year in 2023. Early Life Peter Kolchinsky was born in the United States of America. To their delight, Keri and Ben, long-time city dwellers, were immediately taken with the town and the inn, and they, too, embraced the vision of a life filled with New England hospitality, nature, and, adds Ben, equal parts fly fishing and snow shoveling. The most active insiders traders include Capital Management, L.P.Ra , Capital Management, Llc Kol und Peter Kolchinsky. This free 100-page eBook is based on personal interviews with entrepreneurs, investors, attorneys, and other professionals . . He currently manages a fund that invests in healthcare and biotechnology companies. Anna and Peter discovered Woodstock through Annas participation at the GMHA dressage events. Let us know if you like it and we may post more pieces with this option.) Harvard Divinity School and began doctoral work in Buddhist studies at the University of California, Berkeley. She received a Masters degree in TV production at Boston University and worked in film production in Berlin for several years before returning to Boston, where she met Peter. "And another thread that speaks to need for insurance reform. In this conversation. This ground-breaking new book, The Great American Drug Deal: A New Prescription for Innovative and Affordable Medicines (January 20, 2020), by Peter Kolchinsky, PhD, examines the healthcare landscape through the lens of the biotech social contract with America - the implicit agreement between the biopharmaceutical industry and American society - including the government's role in inventing . S&P 500 Aggregate Buffett-Munger Screener Industry Overview Undervalued Predictable Benjamin Graham Net-Net 52-week/3Y/5Y Lows 52-week/3Y/5Y Highs Magic Formula (Greenblatt) . The Great American Drug Deal examines the healthcare landscape through the lens of this contract, including the government's role in inventing drugs, direct-to-consumer advertising, the opioid crisis, the price-jacking of old drugs, and the impact on America of lower drug costs in other countries. Provides CEO, CFO, Director and Chief Executives trade reports, independent equity research, and stock screening. Dyne Therapeutics, Inc's most recent insider trade came on January 23, 2023 by Stock quotes provided by InterActive Data. and bought an estimated value of $190.71M worth of shares. For a patient who can't afford a $5,000 deductible, even slashing a $50,000 treatment's price by 90% would still leave that patient unable to afford his or her $5,000 out-of-pocket obligation. Its a longstanding agreement between the government and industry to keep medicines affordable for the National Health Service (NHS). He studied philosophy at Oregon State University and then, a law degree from the University of Oklahoma. Anna and Keri hope their husbands dont electrocute themselves in the process. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. Mineralys Therapeutics, Inc's most recent insider trade came on February 16, 2023 by The drug industry stands accused of charging too much. I don't believe that temperature plays a role in the spread of Covid-19. On average, Wave Life Sciences executives and independent directors trade stock every 39 days with the average trade being worth of $949,631. $12.54M on September 23, 2020. 2004-2023 GuruFocus.com, LLC. Please note this link is one-time use only and is valid for only 24 hours. January 3, 2023 Feb 10th, Ed. Keri is currently the Chair of the Religious Studies department at St. Pauls School for Girls in Baltimore, Maryland. In addition, he makes $151,598 as Independent Director at Wave Life Sciences. we figured our friends and family would try to talk us out of it, said Anna. Enjoy a 7-Day Free Trial Thru Mar 12, 2023! The current estimated net worth of Solid Biosciences Inc's Director, Peter Kolchinsky, is estimated to be about $2.7B . It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. Data from the new InnoLead/KPMG US Insider trading is most common in June, with the busiest year in 2022. She received her bachelors degree from Furman University in South Carolina in Philosophy and Asian Studies. I am on Oahu until Friday, so please feel free to also contact me directly in order to discuss This slide deck contains a powerful visual illustration of the biotech industry's race to find a cure for Hepatitis C. Run through the slide deck quickly to appreciate the sheer level of hustle that won the world a cure, and then more slowly to appreciate every move in the chess game of mergers & acquisitions. The largest trade he's ever made was buying 6,337,135 units of Kala Pharmaceuticals Inc stock on 13 March 2020 worth over $49,999,995. But there was a lot of adjusting to do, for everyone in the family. Internal digital and data science expertise is critical to developing a united value proposition that aligns the benefits of the digital and medicinal product. Peter Kolchinsky Oct 5, 2018 Direct-to-Consumer (DTC) advertising: misnamed, misunderstood, and underappreciated Maligned by doctors and often parodied, appropriately regulated. They will be in plain English and use colorful analogies." The most active traders at the company are Peter's wife, Anna, grew up in Germany, Austria, and France, and came to Bost on to attend Wellesley College. Verified account Protected Tweets @; Suggested users Peter Kolchinsky grew up in the Boston area, studied biology at Cornell, and has a PhD in Virology from Harvard. Welcome back to Endpoints Weekly, your review of the weeks top biopharma headlines. You can see the complete history of Peter Kolchinsky stock trades at the bottom of the page. Peter Kolchinsky, Ph.D. is a biotechnology investor and a scientist. Our new neighbors have a vision for The Blue Horse Inn and have already started on renovations to make the house as vibrant from the outside as it is on the inside. Over the last 8 years, insiders at Wave Life Sciences have traded over $18,606,802 worth of Wave Life Sciences stock and bought 14,319,108 units worth $106,704,225 America is rightfully outraged when patients cant afford the medicines they need. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company's proprietary discovery and drug development platform that enables the precise design, optimization and production of stereopure oligonucleotides. Downloadable as a .pptx file. Change), You are commenting using your Twitter account. Peter is active in both public and private investments in companies developing drugs, medical devices, diagnostics, and research . Kolchinsky's new book, The Great American Drug Deal: A New Prescription for Innovative and. Most importantly, this book describes concrete, actionable reforms under which patients will be able to afford their treatments and society will continue to reap the benefits of medical innovation. foundation had somehow failed patients by allowing Vertex to price its drugs so high that a 10 percent royalty could be worth so much. UCLA CTSI | Accelerating Discoveries Toward Better Health | Main (LogOut/ By India Today Web Desk: With more than 22 lakh people infected, more than 1.5 lakh dead of the novel coronavirus, health experts all over the world are scrambling to understand just how did this one virus get so potent.. Many proposed solutions, including drug price controls, threaten to defund innovation but also distract the public from the real problem, which lies in the unraveling of the biotech social contract the implicit agreement between the biopharmaceutical industry and American society. Peter Kolchinsky owns over 4,000,000 units of Wave Life Sciences stock worth over $37,758,818 and over the last 9 years he sold WVE stock worth over $58,095,632. Refer a Friend and Earn One Month of Free Membership. All Rights Reserved. Peter Kolchinsky's largest purchase order was, In total, Peter Kolchinsky has made about, Mineralys Therapeutics, Inc's most recent insider trade came on February 16, 2023 by The RA Capital Nexus Fund closed at just over $300 million, they said in a statement. Gurus may be added or dropped from the GuruFocus site at any time. In the last 16 years, insiders at Dyne Therapeutics, Inc have sold an estimated value of $1.64B Fundamental company data provided by Morningstar, updated daily. https://t.co/y9IG2Z5txl" This . Change), You are commenting using your Facebook account. In this conversation. The estimated Net Worth of Peter Kolchinsky is at least $96 million dollars as of 23 June 2020. Sometimes Anna goes by various nicknames including Anna H Kolchinsky, Anna I Haas, Anna Haas Kolchinsky and Anna Haas Kolchinsky. Verified account Protected Tweets @ Protected Tweets @ Peter Kolchinsky's largest purchase order was, In total, Peter Kolchinsky has made about, Solid Biosciences Inc's most recent insider trade came on January 31, 2023 by The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The most recent stock trade was executed by Chandra Vargeese on 16 February 2023, trading 10,249 units of WVE stock currently worth $41,303. Enjoy a 7-Day Free Trial Thru Mar 12, 2023! Peter served on the Board of Global Science and Technology for the National Academy of Sciences and writes about the biotech social contract. Berkshire Hathaway BRK.B +0.31% 's future leaders, including Greg Abel, will be expected to put many of their financial eggs in the conglomerate's basket. It will take some time, but rest assured: a coronavirus vaccine is coming, and it will work. Shes currently earning her PhD in European History at Boston College. and Catherine James, EVP and General Counsel The Blue Horse Inn (AKA) Number Three Church Street and (AKA) The Lauren has a new name and four new proprietors: Peter, Anna, Ben, and Keri. document.getElementById( "ak_js_1" ).setAttribute( "value", ( new Date() ).getTime() ); Blog at WordPress.com.RSS 2.0Comments RSS 2.0, The Blue Horse Inn (AKA) Number Three Church Street and (AKA) The Lauren has a new name and four new proprietors: Peter, Anna, Ben, and Keri. Fill in your details below or click an icon to log in: You are commenting using your WordPress.com account. Robert Flexon, President and CEO, Jonathan McNeill who sold 10,000 units worth We loved the idea of having a second home that was also an inn, but we figured our friends and family would try to talk us out of it, said Anna. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. A hike is also under consideration for the voluntary scheme. Dr. Peter Kolchinsky Ph.D. serves as Independent Director of the Company. The real solution to affordability is hidden in plain sight amidst all the rhetoric about drug prices. Past performance is a poor indicator of future performance. Executives behind AI and precision medicine startup Tempus are putting together another AI outfit in Chicago focused on oncology drug discovery and development. His wife, Nora Flor, said she and her sister made calls to at least 30 centers across the US looking for the drug. Above is the net worth, insider trading, and ownership report for Kolchinsky Peter. Peter Kolchinsky usually trades in December, with the busiest year in 2022. Industry is going to have to give "a pound of flesh," Kolchinsky argued, and he's explicit on the business practices biopharma must abandon to get a fair system that still rewards innovation. The biopharmaceutical industry will be able to make a Covid-19 vaccineprobably a few of themusing various existing vaccine technologies. Listed on the paperwork are Tempus CEO Eric Lefkofsky and operating chief Ryan Fukushima, who is described as CEO of Pathos. After serving in the US Air Force JAG Corps, Ben worked at a private law firm and in Massachusetts state government. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Peter Kolchinsky. We'll e-mail you a link to set a new password. Anna Kolchinsky was born on 03/30/1979 and is 43 years old. If you are considering starting your own biotech company, you will appreciate the wealth of practical information packed into The Entrepreneur's Guide to a Biotech Startup. Peters wife, Anna, grew up in Germany, Austria, and France, and came to Boston to attend Wellesley College. Opinion. RA Capital is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are . Peter's reported annual income is about $100 - 149,999; with a net worth that tops $50,000 - $99,999. The higher rates are proposed to kick in on April 1. He is active in both public and private investments in companies developing drugs, medical devices, diagnostics and research tools and serves as a board member for various public and privately-held . The URI to TrackBack this entry is: https://bluehorseinnvermont.wordpress.com/2010/03/14/the-blue-horse-six/trackback/. Most recently he bought 4,000,000 units of WVE stock worth $80,000,000 on 23 June 2020. After serving in the US Air Force JAG Corps, Ben, at a private law firm and in Massachusetts, He currently works with the State and Local Government Practice Group of. Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens. Peter Kolchinsky owns over 4,000,000 units of Wave Life Sciences stock worth over $38,029,167 and over the last 9 years he sold WVE stock worth over $58,095,632. Social image: Peter Kolchinsky and Raj Shah, RA Capital Management, Digital therapeutics support increased access to safe and effective therapies, providing an untapped opportunity for biopharmaceutical companies to maximize the value of medicinal assets and drive differentiation How do you see re-infections? The Great American Drug Deal was released on January 20, 2020. Dr. Kolchinsky is a founder and Managing Partner of RA Capital Management, L.P., a multi-stage investment manager which is dedicated to evidence-based investing in healthcare and life science companies that are developing drugs, medical devices, and diagnostics, where he has worked since 2001. magic link that lets you log in quickly without using a password. The foursome plans to open for guests in the late spring of 2010. More Ben Ford was born and raised in Ames, Iowa. Past performance is a poor indicator of future performance. venue for exploring their particular passions. Eric Lefkofsky, Tempus founder and CEO (Photo by Michael Kovac/Getty Images), Christina Aguilera joins Merz Aesthetics' 'Beauty on Your Terms' campaign for Botox rival Xeomin, Hemolytic Anemia Sales Specialist, Rare Genetic Diseases, Peter Kolchinsky and Raj Shah raise a $300M fund devoted to biotech startups, Digital therapeutics: The key to maximizing the potential of medicinal assets, What latest wave of layoffs means for biotech; Radiotherapy shortage; Delivering on mRNA's promises; and more, Harder to find homes: Latest wave of biotech layoffs could test the industry, Esperion unveils long-awaited data on cholesterol pill's ability to cut cardiovascular risk, Tempus founders build a drug discovery startup, Pathos AI, with $40M in sight, A radioactive prostate cancer therapy is a last lifeline for patients. Peter Kolchinsky The Great American Drug Deal: A New Prescription for Innovative and Affordable Medicines Paperback - Illustrated, January 17, 2020 by Peter Kolchinsky (Author) 180 ratings See all formats and editions Kindle $9.99 Read with Our Free App Audiobook $0.00 Free with your Audible trial Paperback Peter is active in both public and private investments in companies developing drugs, medical devices, diagnostics, and research tools and serves on the boards of publicly- and privately-held life science companies. Want this in your inbox every Saturday morning? Peter Kolchinsky's largest purchase order was, In total, Peter Kolchinsky has made about, Dyne Therapeutics, Inc's most recent insider trade came on January 23, 2023 by